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Dinuclear ruthenium(II) complexes containing one
inert metal centre and one coordinatively-labile
metal centre: syntheses and biological activities
Xin Li,a Kirsten Heimann,b,c Fangfei Li,†a Jeffrey M. Warner,c,d F. Richard Keene*c,e,f
and J. Grant Collins*a
A series of non-symmetric dinuclear polypyridylruthenium(II) complexes (Rubbn-Cl) that contain one inert
metal centre and one coordinatively-labile metal centre, linked by the bis[4(4’-methyl-2,2’-bipyridyl)]-
1,n-alkane ligand (“bbn” for n = 7, 12 and 16), have been synthesised and their potential as antimicrobial
agents examined. The minimum inhibitory concentrations (MIC) of the ruthenium(II) complexes were
determined against four strains of bacteria − Gram-positive Staphylococcus aureus (S. aureus) and methi-
cillin-resistant S. aureus (MRSA), and Gram-negative Escherichia coli (E. coli) and Pseudomonas aerugi-
nosa (P. aeruginosa). The Rubbn-Cl complexes displayed good antimicrobial activity, with Rubb12-Cl
being the most active complex against both Gram-positive and Gram-negative strains. Interestingly,
Rubb7-Cl was found to be eight- and sixteen-fold more active towards E. coli than against S. aureus and
MRSA, respectively. The cytotoxicities of the Rubbn-Cl complexes against three eukaryotic cell lines –
two kidney cell lines (BHK and HEK-293) and one liver cell line (HepG2) – were examined. The Rubbn-Cl
complexes were found to be considerably less toxic towards eukaryotic cells than S. aureus, MRSA and
E. coli, with Rubb12-Cl being thirty- to eighty-times more toxic to the bacteria than to BHK, HEK-293 or
HepG2 cells. Unexpectedly, Rubb7-Cl was far more toxic to HepG2 cells (24 h-IC50 = 3.7 μM) and far less
toxic to BHK cells (24 h-IC50 = 238 μM) than the Rubb12-Cl and Rubb16-Cl complexes. In order to under-
stand the unexpected large differences in the cytotoxicities of the Rubbn-Cl complexes towards eukaryo-
tic cells, a confocal microscopic study of their intracellular localisation was undertaken. The results
suggest that the observed cytotoxicity might be related to the extent of DNA binding.
Introduction
The emergence of drug-resistant populations of microorgan-
isms has become a serious worldwide health issue.1 There is
clearly a need for new antimicrobials; however more impor-
tantly, new classes of antimicrobials are needed rather than
drugs based upon analogues of known scaffolds.
Traditionally, the design and development of new anti-
microbial drugs has centred upon organic chemistry. However,
due to the success of cisplatin as an anticancer drug and the
established ability of transition metal complexes to bind DNA
and RNA,2–6 there has been increasing interest in using metal
complexes as antimicrobial agents.7–14 Among the transition
metal complexes, ruthenium-based complexes have drawn
increasing attention.9–14 Dwyer and co-workers were the first to
report the biological activity of mononuclear tris(bidentate)
inert polypyridyl metal complexes, in particular complexes
with 1,10-phenanthroline ligands.9,10 [Ru(phen)3]
2+ was found
to be inactive; however, the introduction of methyl substitu-
ents on the phen ligands dramatically increased the activity
against all bacteria.9,10 More recently, it has been demonstrated
that polypyridylruthenium(II) complexes which bind DNA by
intercalation have significant bactericidal activity, particularly
against Gram-positive strains.11,12 While DNA binding is gener-
ally thought to be responsible for the antimicrobial activity of
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polypyridylruthenium(II) complexes, Lam et al. suggested that
the antimicrobial activity of a bis(bipyridine)ruthenium(II)
complex containing a N-phenyl-substituted diazafluorene
ligand might be due to DNA damage caused by the formation
of reactive oxygen species.15 In addition, a range of labile
ruthenium(II) and ruthenium(III) complexes have shown anti-
microbial activity.16,17
We have recently demonstrated that dinuclear polypyridyl-
ruthenium(II) complexes containing a flexible bis[4(4′-methyl-
(-2,2′-bipyridyl)]-1,n-alkane (bbn) bridging ligand (see Fig. 1)
have good antimicrobial activity.18–21 These ruthenium com-
plexes were highly active against a range of pathogenic bac-
teria, particularly Gram-positive strains,18 and maintained the
activity against drug-resistant bacteria, including strains that
are of considerable current concern, e.g. methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant Entero-
coccus (VRE). Furthermore, preliminary toxicity experiments
indicated the dinuclear Rubbn complexes were significantly
less toxic to eukaryotic cells.22,23 Based upon the good anti-
microbial activity and cell selectivity of the Rubbn complexes,
corresponding tri- and tetra-nuclear inert ruthenium com-
plexes were subsequently synthesised.24 These complexes gene-
rally showed better activities than the dinuclear analogues and
were more active against Gram-positive species.24
In another approach, we have also examined the effects of
incorporating labile chlorido groups into dinuclear ruthenium
(II) complexes linked by the bbn ligand, [{Ru(tpy)Cl}2{μ-bbn}]2+
(Cl-Rubbn-Cl; where tpy = 2,2′:6′,2″-terpyridine),
25 see Fig. 2.
The symmetrical Cl-Rubbn-Cl complexes showed good activity
against both Gram-positive bacteria and Gram-negative
species. However, incorporation of the chlorido groups did sig-
nificantly affect the relative activities of the ruthenium com-
plexes, compared to the corresponding inert Rubbn complexes.
Whereas the order of activities for the inert complexes was
Rubb16 ≥ Rubb12 > Rubb7, it was found that Cl-Rubb12-Cl was
the most active of the Cl-Rubbn-Cl complexes and Cl-Rubb16-Cl
was slightly less active than the Cl-Rubb7-Cl complex. Taken
together, the combined results highlight the balance between
cationic charge and lipophilicity; however, it is not yet clear
where the optimal charge/lipophilicity balance lies. In order to
help clarify this issue, we aimed to synthesise and examine the
antimicrobial activities of dinuclear ruthenium complexes that
contained one inert metal centre and one metal centre that
incorporated a chlorido ligand (Rubbn-Cl complexes, see
Fig. 2).
In this study, the synthesis and the antimicrobial properties
of the non-symmetrical Rubbn-Cl complexes (for n = 7, 12 and
16) against Gram-positive S. aureus and MRSA, and Gram-
negative Escherichia coli and Pseudomonas aeruginosa were
examined. As the clinical potential of any new drug is deter-
mined by both the antimicrobial activity and the associated
toxicity towards eukaryotic cells, the cytotoxicities of the
Rubbn-Cl complexes against three eukaryotic cell lines were
also examined. In order to understand the unexpected large
differences in the cytotoxicities of the Rubbn-Cl complexes
towards eukaryotic cells, a confocal microscopic study of their
intracellular localisation was also undertaken.
Experimental
Physical measurements and materials
1H NMR spectra were recorded on a Varian Unityplus 400 MHz
spectrometer with chemical shifts reported as δ values relative
to the signal of tetramethylsilane. The NMR solvents D2O
(99.9%), CD2Cl2 (99.8%), CDCl3 (99.8%), CD3CN (99.8%) and
DMSO-d6 (99.9%) were obtained from Cambridge Isotope Labo-
ratories. Microanalyses were performed by the Microanalytical
Unit, Research School of Chemistry, Australian National
University. High-resolution mass spectral measurements were
made using a Waters LCT mass spectrometer (Research School
of Chemistry, Australian National University). 4,4′-Dimethyl-
2,2′-bipyridine (Me2bpy), lithium di-isopropylamide (LDA), 1,5-
dibromopentane, 1,10-dibromodecane, 1,14-dibromotetra-
decane, 2;2′,6′;2″-terpyridine (tpy), and 1,10-phenanthroline
(phen) were purchased from Sigma-Aldrich, and RuCl3·xH2O
from American Elements. For the nucleotides used, 5′-GMP
(di-sodium salt) was obtained from Sigma-Aldrich while
5′-AMP, 5′-CMP and 5′-UMP (sodium salts) were from Apollo
Fig. 1 Structure of the Rubbn complexes (n = 7, 12 and 16).
Fig. 2 Structures of the Cl-Rubbn-Cl and the Rubbn-Cl complexes (n =
7, 12 and 16).
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chemicals, Burlington, US. All chemicals were used as
supplied.
The mononuclear ruthenium complex [Ru(tpy)(Me2bpy)Cl]
Cl was synthesised as previously described.26 The synthesis of
the bridging ligands bbn (n = 7, 12 and 16; A) were performed
in a similar manner to that reported in the literature.27
The precursors [Ru(tpy)Cl3] (B) [Ru(phen)2Cl2]Cl (C),
[Ru(phen)2Cl2] (D), [Ru(phen)2(py)2]Cl2 (E; py = pyridine) and
rac-[Ru(phen)2(bbn)](PF6)2 (F) were prepared according to
previously reported methods.27–29
Synthesis of [Ru(phen)2(μ-bbn)Ru(tpy)Cl]Cl3 (Rubbn-Cl,
n = 7, 12 and 16, G)
For [Ru(phen)2(μ-bb7)Ru(tpy)Cl]Cl3, solid [Ru(tpy)Cl3] (10 mg,
0.032 mmol) and [Ru(phen)2(bb7)](PF6)2 (3.7 mg, 0.032 mmol)
were refluxed in ethanol/water (4 : 1, 10 mL) for 3 h. After
cooling, excess NH4PF6 was added to precipitate a dark-brown
material which was filtered and washed with ethanol. The
crude product was then loaded onto a Sephadex LH20 size-
exclusion column and eluted with acetone. The
[Ru(phen)2(μ-bb7)Ru(tpy)Cl](PF6)3 fraction was obtained as the
major dark-brown band which was isolated and evaporated to
dryness. The PF6
− salt was converted to the chloride (meta-
thesis) by dissolving the solid in the minimum amount of
acetone followed by the dropwise addition of a saturated solu-
tion of tetraethylammonium chloride in acetone with stirring
for 30 min. The resulting fluffy precipitate was centrifuged,
decanted, washed several times with cold acetone and dried
under reduced pressure to afford [Ru(phen)2(μ-bb7)Ru(tpy)Cl]
Cl3 (yield 70–80%). Separation of the possible geometric
isomers (the chlorido ligand in the coordinatively-labile metal
centre can potentially be either cis or trans to the pyridine ring
of the bbn ligand bearing the methyl group – the trans disposi-
tion is shown in Fig. 2) was not attempted.
[Ru(phen)2(μ-bb7)Ru(tpy)Cl]Cl3 (Rubb7-Cl). 1H NMR
(CD2Cl2): δ = 10.09 (d, J = 6.2 Hz, 1H), 8.58 (d, J = 8.0 Hz, 2H),
8.47 (d, J = 8.0 Hz, 2H), 8.30–8.38 (m, 4H), 8.17–8.22 (m, 8H),
8.07 (s, 1H), 8.00 (t, J = 8.3 Hz, 1H), 7.79–7.88 (m, 6H), 7.71 (d,
J = 4.2 Hz, 1H), 7.61–7.66 (m, 4H), 7.43–7.50 (m, 2H), 7.23 (t,
J = 5.8 Hz, 2H), 7.13 (s, 2H), 6.99 (dd, J = 5.8, 10.8 Hz, 1H), 6.75
(s, 1H), 3.03 (s, 1H), 2.86 (s, 3H), 2.79 (s, 2H), 2.56 (s, 3H), 2.36
(s, 2H), 2.12 (s, 3H), 1.48–1.65 (m, 10H). 13C NMR (CD3CN):
159.8, 159.1, 158.0, 156.8, 155.9, 153.6, 152.9, 152.2, 152.1,
152.0, 151.4, 149.8, 149.0, 148.9, 148.7, 137.7, 137.6, 137.5,
134.1, 131.9, 129.0, 127.8, 127.0, 125.7, 125.4, 124.8, 124.6,
124.5, 123.4, 35.8, 35.6, 35.5, 35.2, 31.0, 30.8, 30.8, 30.7, 29.7,
29.6, 29.5, 29.4, 21.3, 21.1, 20.8. TOF MS (ESI+): m/z 442.7 (for
[M − 3Cl]3+); calcd for Ru2[C68H59N11Cl]3+: m/z 442.6; m/z
651.6 (for [M − 2Cl]2+); calcd for Ru2[C68H59N11Cl2]2+: m/z
651.7; m/z 1347.2 (for [M]); calcd for Ru2[C68H59N11Cl4]: m/z
1374.2. Anal. Calcd for C68H59ClF18N11P3Ru2 {[Ru(phen)2-
(μ-bb7)Ru(tpy)Cl](PF6)3}: C, 48.0; H, 3.49; N, 9.0%. Found:
C, 48.0; H, 3.52; N, 8.9%.
[Ru(phen)2(μ-bb12)Ru(tpy)Cl]Cl3 and [Ru(phen)2(μ-bb16)-
Ru(tpy)Cl]Cl3 were synthesised using an analogous procedure
as that for [Ru(phen)2(μ-bb7)Ru(tpy)Cl]Cl3 but with the appro-
priate bbn bridging ligand.
[Ru(phen)2(μ-bb12)Ru(tpy)Cl]Cl3 (Rubb12-Cl). 1H NMR
(CD2Cl2): δ = 10.13 (d, J = 6.0 Hz, H), 8.59 (d, J = 7.8 Hz, 2H),
8.47 (d, J = 7.8 Hz, 2H), 8.34 (d, J = 7.8 Hz, 2H), 8.17–8.30 (m,
11H), 8.00–8.05 (m, 2H), 7.83–7.90 (m, 6H), 7.74 (d, J = 5.6 Hz,
1H), 7.62–7.67 (m, 4H), 7.50 (d, J = 5.6 Hz, 1H), 7.45 (m, 1H),
7.26 (m, 2H), 7.15 (m, 1H), 7.02 (dd, J = 5.6, 9.2 Hz, 1H), 6.77
(m, 1H), 2.80 (s, 3H), 2.68 (s, 3H), 2.57 (s, 2H), 2.42 (s, 2H),
1.20–1.68 (m, 20H). 13C NMR (CD3CN): 159.7, 159.1, 157.9,
156.7, 155.8, 154.2, 153.6, 152.9, 152.6, 152.5, 152.2, 151.3,
148.9, 148.6, 137.7, 137.6, 137.5, 134.1, 131.9, 129.0, 128.3,
128.1, 127.1, 126.9, 126.8, 126.1, 125.3, 124.4, 124.3, 123.4,
35.9, 35.6, 31.8, 31.1, 30.9, 30.7, 30.3, 30.2, 30.1, 30.0, 29.9,
29.8, 29.6, 21.4, 21.1. TOF MS (ESI+): m/z 446.1 (for [M −
3Cl]3+); calcd for Ru2[C73H69N11Cl]
3+: m/z 446.0; m/z 686.7 (for
[M − 2Cl]2+); calcd for Ru2[C73H69N11Cl2]2+: m/z 686.7. Anal.
Calcd for C73H77O4Cl4N11Ru2 {[Ru(phen)2(μ-bb12)Ru(tpy)Cl]-
(Cl)3·4H2O}: C, 57.8; H, 5.12; N, 10.2%. Found: C, 57.9; H,
5.11; N, 10.2%.
[Ru(phen)2(μ-bb16)Ru(tpy)Cl]Cl3 (Rubb16-Cl). 1H NMR
(CD2Cl2): δ = 10.11 (d, J = 6.2 Hz, 1H), 8.57 (d, J = 7.4 Hz, 2H),
8.45 (d, J = 7.4 Hz, 2H), 8.32 (d, J = 7.4 Hz, 2H), 8.13–8.25 (m,
11H), 7.97–8.03 (m, 2H), 7.81–7.87 (m, 6H), 7.71 (d, J = 6.6 Hz,
1H), 7.60–7.64 (m, 4H), 7.47 (m, 1H), 7.42 (d, J = 6.6 Hz, 1H),
7.25 (m, 2H), 7.14 (t, J = 5.6 Hz, 2H), 7.00 (t, J = 6.8 Hz, 1H),
6.75 (m, 1H), 2.78 (s, 3H), 2.55 (s, 3H), 2.35 (s, 2H), 2.11 (s,
2H), 1.19–1.56 (m, 28H). 13C NMR (CD3CN): 159.7, 159.1,
157.9, 156.7, 155.7, 153.6, 153.5, 152.9, 152.5, 152.3, 152.1,
151.3, 149.7, 148.9, 148.9, 148.6, 137.7, 137.6, 137.5, 134.2,
131.9, 129.0, 128.3, 128.1, 127.9, 127.1, 126.9, 126.8, 126.0,
125.2, 125.1, 125.0, 124.4, 124.3, 123.4, 35.9, 35.6, 35.3, 31.1,
30.8, 30.7, 30.3, 30.2, 30.2, 30.1, 30.0, 29.8, 29.6, 21.4, 21.7,
20.8. TOF MS (ESI+): m/z 464.8 (for [M − 3Cl]3+); calcd for
Ru2[C77H77N11Cl]
3+: m/z 464.7; m/z 714.7 (for [M − 2Cl]2+);
calcd for Ru2[C77H77N11Cl2]
2+: m/z 714.8. Anal. Calcd for
C77H77ClF18N11P3Ru2 {[Ru(phen)2(μ-bb16)Ru(tpy)Cl](PF6)3}:
C, 50.6; H, 4.24; N, 8.4%. Found: C, 50.7; H, 4.42; N, 8.2%.
Δ-[Ru(phen)2(μ-bbn)Ru(tpy)Cl]Cl3 complexes were syn-
thesised following the same procedure as that for the racemic
mixtures, using Δ-[Ru(phen)2(bbn)](PF6)2 (n = 7, 12 and 16) as
precursors. CD spectra: Δ-Rubb7-Cl {λ/nm (Δε/cm−1 M−1)
H2O}: 290 (−374.3), 281 (−294.2), 272 (−405.1), 261 (469.3),
233 (27.3), 221 (77.5). Δ-Rubb12-Cl {λ/nm (Δε/cm−1 M−1) H2O}:
290 (−356.7), 281 (−244.3), 271 (−352.3), 261 (412.8), 228
(10.5), 213 (107.4). Δ-Rubb16-Cl {λ/nm (Δε/cm−1 M−1) H2O}:
288 (−364.4), 279 (−285.9), 271 (−358.7), 260 (393.6), 227
(39.2), 221 (80.5).
Aquation of Rubbn-Cl complexes
The ruthenium complexes [Ru(tpy)(Me2bpy)Cl]Cl and
Δ-Rubb7-Cl were dissolved in D2O (650 µL) to give 1.0 mM
solutions. 1H NMR spectra were then recorded as a function of
time at 25 °C.
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Reaction of ruthenium complexes with nucleotides
Reactions with nucleotides were carried out after the aquation
of the chlorido-containing ruthenium complexes had reached
equilibrium. The nucleotides 5′-GMP, 5′-AMP, 5′-CMP, and
5′-UMP were dissolved in D2O and separately added to the
ruthenium complexes (1 mM) dissolved in D2O at the desired
[Ru complex] : [nucleotide] ratio. 1H NMR spectra were
recorded as a function of time after mixing the sample
thoroughly. NOESY experiments were conducted using the
method of States et al.,30 with 1024 data points in t2 for 256 t1
values, a pulse repetition delay set to 1.5 s and mixing times
from 100 to 500 ms. Correlation spectroscopy experiments
(DQFCOSY) were recorded using the same t1, t2 and pulse
repetition values.
Molecular modelling was performed using HyperChem.31
Energy minimisation by Polak–Ribiere conjugate-gradient
refinement was carried out with the metal complex treated as
a rigid group. The ruthenium complex was manually docked to
the GMP to reflect observed intermolecular NOEs.
Bacterial strains
Note: the bacterial strains used in this study are classified as
risk group 2 according to the Australian/New Zealand Standard
(AS/NZS 2243.4:2010) and accordingly were manipulated in a
PC2 class laboratory. Gram-positive isolates {a methicillin-sus-
ceptible S. aureus strain (ATCC 25923) and a clinical, multi-
drug-resistant, MRSA strain (JCU culture collection)}, and two
Gram-negative isolates {E. coli (ATCC 25922) and P. aeruginosa
(ATCC 27853)}, were used for antimicrobial studies.
Determination of minimum inhibitory concentration (MIC)
MIC values were determined in duplicate by standard micro-
dilution methodology in CAMHB,32 using gentamicin as the
positive control, as previously described.18,19
Determination of minimum bactericidal concentration (MBC)
The MBC tests were performed in duplicate according to a
standard microbiological techniques protocol,33 as previously
described.18,19
Cell culture
Two kidney cell lines {BHK (baby hamster kidney) and
HEK-293 (embryonic kidney)}, and one liver cell line {HepG2
(liver carcinoma)} were used in this study. All cell lines were
generously supplied by the Australian Army Malaria Institute
(AMI, Enoggera, QLD, Australia), and originated from the
American Type Culture Collection (ATCC, Manassas, USA).
Cells were cultured as previously described.22 Cells used in the
study were in the logarithmic growth phase and were grown to
70% confluence, and then trypsinised with 0.25% trypsin–
0.02% EDTA (Sigma-Aldrich) for detachment and used in the
assays described below.
Half-maximal inhibitory concentration (IC50) cytotoxicity assay
Half-maximal inhibitory concentrations (IC50) of the ruthe-
nium complexes were assessed using the Alamar Blue cyto-
toxicity assay (Invitrogen, Carlsbad, USA) as previously
described.22,34
Cellular localisation of the ruthenium complexes
Trypsinised HepG2 or BHK cells were seeded in Lumox® multi-
well plates (Sarstedt, Numbrecht, Germany), and incubated
with 5 to 100 μM ruthenium complexes at 37 °C with 5% CO2
for 20 h. Following incubation, cells were stained with 100 nM
Mitotracker® Green FM (Invitrogen, Carlsbad, USA) for mito-
chondrial staining, 100 nM DAPI (4′,6-diamidino-2-phenyl-
indole; Invitrogen) for nuclear staining and/or 50 nM SYTO 9
(Invitrogen) for nucleolus staining. Staining was carried out in
RPMI-1640 medium under standard cultivation conditions as
per the manufacture’s instructions. Following staining, cells
were gently rinsed with phosphate buffer solution (PBS; pH =
7.1) prior to confocal laser scanning microscopy.
The cellular localisation of the ruthenium complexes was
determined using a Zeiss laser scanning confocal microscope
(LSM 700, Carl Zeiss, Göttingen, Germany). Samples were
viewed under a 63× oil immersion lens. The ruthenium com-
plexes (λex = 450 nm, λem = 610 nm), Mitotracker Green FM
(λex = 490 nm, λem = 516 nm) and SYTO 9 (λex = 486 nm, λem =
501 nm) were excited using a blue argon laser (λex = 488 nm),
and emissions were collected over the range 570–650 nm for
the metal complexes, 470–550 nm for Mitotracker and
495–510 nm for SYTO 9. For DAPI excitation, a diode laser
(λex = 405 nm) was used and the emission detected at
430–500 nm. Image data acquisition and processing was
performed using Zen software 2009 (Carl Zeiss).
Results
Synthesis of Rubbn-Cl (n = 7, 12 and 16) complexes
The syntheses of the symmetric oligonuclear polypyridine
ruthenium complexes Rubbn, Tri-Rubbn, Tetra-Rubbn and
Cl-Rubbn-Cl have been previously reported and their biological
properties have been thoroughly studied.18–25 To obtain a
better structure–activity relationship, a new class of non-
symmetric dinuclear ruthenium complexes Rubbn-Cl was
designed and synthesised. The Rubbn-Cl complexes were pre-
pared from [Ru(phen)2(py)2]
2+ (E), [Ru(tpy)Cl3] (B) and the bbn
ligand (A) following the synthetic route shown in Scheme 1,
with the final dinuclear product Rubbn-Cl (G) obtained
through reaction of [Ru(phen)2bbn]
2+ (F) with [Ru(tpy)Cl3].
[Ru(phen)2(py)2]
2+ and [Ru(phen)2bbn]
2+ were purified by
cation-exchange chromatography on an SP Sephadex C-25
column, whereas the final Rubbn-Cl complexes were purified
by size-exclusion on a Sephadex LH20 column. The Rubbn-Cl
complexes were characterised by 1H and 13C NMR, microanaly-
sis and ESI-MS.
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Aquation of chlorido-containing ruthenium complexes
As the Rubbn-Cl complexes are activated towards covalent
bond formation with intracellular targets by aquation, a study
of the aquation of Rubb7-Cl and the parent complex [Ru(tpy)-
(Me2bpy)Cl]
+ was carried out. The rate of aquation of [Ru(tpy)-
(Me2bpy)Cl]
+ has been previously determined by 1H NMR
spectroscopy,26 where the concomitant disappearance of the
resonance from the H6 of the Me2bpy ligand from the chlorido
complex and the emergence of the corresponding resonance
from the aqua species were monitored as a function of time.
By following the disappearance of the H6 resonance of
the Me2bpy ligand for [Ru(tpy)(Me2bpy)Cl]
+ (9.71 ppm) and
Rubb7-Cl (9.52 ppm) and the emergence of the corresponding
resonance of the aqua complexes (9.52 and 9.24 ppm,
respectively), it was determined that 50% aquation is achieved
Scheme 1
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in 90 minutes for [Ru(tpy)(Me2bpy)Cl]
+ and 210 minutes for
Rubb7-Cl (see Fig. 3).
Reaction of [Ru(tpy)(Me2bpy)(D2O)]
2+ with nucleotides
The covalent binding of [Ru(tpy)(Me2bpy)(D2O)]
2+ with each of
the di-anions of guanosine monophosphate (5′-GMP), cytidine
monophosphate (5′-CMP), adenosine monophosphate
(5′-AMP) and uridine monophosphate (5′-UMP) was studied.
After a 24-hour incubation of [Ru(tpy)(Me2bpy)(D2O)]
2+ with
each nucleotide, the 1H NMR spectrum was recorded and the
spectra are shown in Fig. 4. Addition of AMP, CMP and UMP
to [Ru(tpy)(Me2bpy)(D2O)]
2+ only resulted in the slight broaden-
ing of the nucleotide resonances without the emergence of
new peaks, suggesting a weak reversible association between
the ruthenium complex and the nucleotides. However,
24 hours after the addition of GMP to [Ru(tpy)(Me2bpy)-
(D2O)]
2+ distinct differences in the NMR spectrum were
observed. The absence of a resonance at 9.71 ppm (H6 of
Me2bpy of the chlorido species) indicated that the equilibrium
had shifted towards the aqua complex. Furthermore, a small
second set of broad peaks emerged, indicating the formation
of a covalently-bound adduct. Based upon the relative integrals
of the sugar H1′ of the free GMP (5.90 ppm) and ruthenium
complex-bound GMP (5.50 ppm), approximately 35% of the
GMP covalently bound [Ru(tpy)(Me2bpy)(D2O)]
2+ in 24 hours.
Given the observed preferential binding of [Ru(tpy)(Me2bpy)-
(D2O)]
2+ with GMP, further studies were only carried out with
GMP. Fig. 5 shows the 1H NMR spectrum of [Ru(tpy)(Me2bpy)-
(D2O)]
2+ with added GMP as a function of time, and after the
addition of further GMP after 64 hours. The H8 of GMP was
tentatively assigned by heating the sample at 50 °C for
16 hours. The H8 of GMP will slowly exchange with a deuter-
ium in the D2O solvent at 50 °C; e.g. see the reduction in inten-
sity of the H8 of the free GMP in Fig. 5D and E. Consequently,
the singlet resonance at 6.56 ppm could be assigned to the H8
of bound GMP.
The assignment of the proton resonances from the [Ru(tpy)-
(Me2bpy)GMP] adduct was determined from DQFCOSY and
Fig. 3 (A) The relative proportions of [Ru(tpy)(Me2bpy)Cl]
+ and [Ru(tpy)(Me2bpy)(D2O)]
2+ as a function of time after dissolving the chlorido species
in D2O; (B) the relative proportions of Rubb7-Cl and Rubb7-D2O as a function of time after dissolving the chlorido form in D2O.
Fig. 4 1H NMR spectra of [Ru(tpy)(Me2bpy)(D2O)]
2+ and either UMP, CMP, AMP and GMP, at a ruthenium complex to nucleotide ratio of 2 : 1, in D2O
after a 24 hour incubation. In the spectrum of [Ru(tpy)(Me2bpy)(D2O)]
2+ with GMP the arrows indicate the new peaks due to the covalent adduct.
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NOESY spectra (data not shown). In the NOESY spectrum of
the aromatic to sugar H1′ region, strong NOE cross peaks were
observed between the tpy H6 and H6″, H5 and H5″, H4 and
H4″, H3 and H3″ and H3′ and H5′, indicating the tpy protons
were in slow exchange (on the NMR time scale) between two
forms. Due to rotation around the Ru–N7 bond, it is possible
that [Ru(tpy)(Me2bpy)GMP] complex may exist in two confor-
mers that are in slow exchange. An NOE cross peak between
the H8 and sugar H1′ of the bound GMP at 6.56/5.50 ppm
provided further support for the assignment of the H8 of
the bound GMP. Based on the NMR analysis, the binding
site of ruthenium complex is most likely at the N7 of the
GMP, given the large shift observed for the GH8 resonance.
A molecular model of the ruthenium complex-GMP adduct is
shown in Fig. 6. In the model, the GMP H8 is positioned
directly below the tpy aromatic rings, which may explain the
unusual upfield shift observed for the resonance upon
N7-metallation.
The time-course 1H NMR spectra of the reaction between
the dinuclear complex Rubb7-Cl and GMP also showed the
emergence of resonances for the ruthenium complex-GMP
adduct (data not shown). A singlet at 6.65 ppm could be
assigned to the H8 from bound GMP, and new broad peaks in
the 8.7–8.9 ppm region were possibly from the bound metal
complex. These observations were similar to those from the
reaction between [Ru(tpy)(Me2bpy)Cl]
+ and GMP, described
Fig. 5 1H NMR spectra of the reaction between [Ru(tpy)(Me2bpy)(D2O)]
2+ and GMP. A, B and C are time-course experiments with the [Ru] : [GMP] =
1 : 1 at 25 °C at 10 minutes, 6 hours and 64 hours after starting the reaction, respectively; D after the addition of three more equivalents of GMP to
give a [Ru] : [GMP] = 1 : 4; E spectrum after D was heated at 50 °C for 16 hours, black arrow indicates GH8 in the bound adduct.
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above, suggesting that Rubb7-Cl interacts with GMP by
forming a covalent bond.
Antimicrobial activity
The minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) values for the Rubbn-Cl com-
plexes against S. aureus, MRSA, E. coli and P. aeruginosa were
determined and are summarised in Table 1. All Rubbn-Cl com-
plexes showed significant activity against both the Gram-nega-
tive and Gram-positive strains, with the Gram-negative strain
P. aeruginosa being the least susceptible. Overall, Rubb12-Cl
showed the best activity across the Rubbn-Cl series. Compared
to Rubb12-Cl, Rubb16-Cl was similarly active against the two
Gram-positive strains, but showed considerably lower activity
against the Gram-negative strains. On the other hand, Rubb7-Cl
was less active than Rubb12-Cl against the Gram-positive
strains, but equally as active as Rubb12-Cl against the Gram-
negative bacteria. As the MBC values were ≤2 × MIC, it is con-
cluded that all the Rubbn-Cl complexes are bactericidal, rather
than bacteriostatic. The Rubbn-Cl complexes generally showed
similar or better activity than the Rubbn and Cl-Rubbn-Cl com-
plexes, with Rubb12-Cl exhibiting as good an activity profile as
any of the other previously-reported ruthenium complexes
linked by the bbn ligand, including the tri- and tetra-nuclear
inert complexes.18,24
Over the four bacteria examined in this study, Rubb7-Cl and
Rubb12-Cl showed slightly better antimicrobial activities com-
pared to their inert analogues, Rubb7 and Rubb12. Conversely,
Rubb16-Cl displayed slightly lower activity than Rubb16. Inter-
estingly, Rubb7-Cl and Rubb12-Cl show better activities against
the two Gram-negative species E. coli and P. aeruginosa than
Rubb7 and Rubb12, respectively. Particularly noteworthy is the
activity of Rubb7-Cl against E. coli compared to the Gram-
positive species S. aureus and MRSA: Rubb7-Cl is eight- and
sixteen-fold more active towards E. coli than against S. aureus
and MRSA, respectively. This preferential activity towards a
Gram-negative species is very unusual for metal-based anti-
microbial agents.
Cytotoxicity against eukaryotic cells and selective activity
To further evaluate the potential of the ruthenium complexes
as antimicrobial agents, an understanding of their cytotoxicity
towards mammalian cells is necessary. The cytotoxicities of
the ruthenium complexes against the kidney cell lines BHK
and HEK-293 were determined for incubation times of
24 hours. As there were no differences in the cytotoxicities
(within experimental error) between the Δ-Rubbn-Cl and the
rac-Rubbn-Cl complexes in preliminary experiments, the rac-
Rubbn-Cl complexes were used to determine the 24-hour IC50
values. The 24 h-IC50 values of the Rubbn-Cl and Rubbn com-
plexes are summarised in Table 2.
Generally, the complexes with a longer linking chain were
more toxic to the cells. Among the rac-Rubbn-Cl complexes,
Rubb16-Cl was the most toxic complex towards BHK and
HEK-293 cells. In contrast, Rubb7-Cl was nontoxic (>200 µM)
towards BHK but showed moderate cytotoxicity towards
HEK-293, while Rubb12-Cl showed similar cytotoxicity towards
both cell lines. These observations suggest that the linking
chain length plays an important role in their cytotoxicities.
The inert complexes ΔΔ-Rubb12 and ΔΔ-Rubb16 also showed
the same trend with ΔΔ-Rubb16 being more toxic than
ΔΔ-Rubb12.
The good antimicrobial activity of the ruthenium complexes
suggests they may have potential as antimicrobial agents.
Fig. 6 A molecular model of [Ru(tpy)(Me2bpy)GMP].
Table 1 MIC and MBC values (µM) for the Rubbn-Cl complexes and the corresponding dinuclear inert Rubbn complexes. MIC values, after
14–16 hours of incubation, were determined as mg L−1 but converted to μM for direct comparison with the IC50 data obtained with eukaryotic cells
Complexes
S. aureus MRSA E. coli P. aeruginosa
MIC MBC MIC MBC MIC MBC MIC MBC
Δ-Rubb7-Cl 5.6 11.2 11.2 22.4 0.7 0.7 11.2 22.4
Δ-Rubb12-Cl 0.7 0.7 0.7 1.4 0.7 0.7 11.2 11.2
Δ-Rubb16-Cl 0.7 0.7 1.4 1.4 2.7 2.7 43.2 43.2
ΔΔ-Rubb7 10.7 21.3 10.7 21.3 10.7 10.7 85.3 >85
ΔΔ-Rubb12 0.7 1.3 0.7 1.3 1.3 1.3 20.4 20.4
ΔΔ-Rubb16 0.6 0.6 0.6 1.2 1.2 1.2 9.8 9.8
Gentamicin 0.4 0.8 28 >200 0.8 0.8 1.6 3.2
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However, to be clinically useful as antimicrobial agents, it is
desirable that the compounds exhibit significantly greater
toxicity towards bacterial cells than mammalian cells. Table 2
also summarises the selectivity indices (SI, 24 h-IC50/MIC)
between the BHK and HEK-293 cell lines and the Gram-posi-
tive bacterium S. aureus and the Gram-negative species E. coli.
In general, the SI values demonstrated that all the ruthenium
complexes were more toxic against bacterial cells than eukaryo-
tic cells, with the SI values ranging from 8–340. Noticeably,
Rubb7-Cl displayed the highest SI values for both BHK and
HEK-293 cells against E. coli. Of particular note, the SI value of
340 between BHK and E. coli was at least five-times higher
than with the other complexes. By contrast, Rubb12-Cl showed
similar selectivity towards S. aureus and E. coli, compared to
both kidney cell lines. The inert complex Rubb12 displayed a
better selectivity for S. aureus than E. coli against both kidney
cell lines. Taken together, Rubb12-Cl exhibited the best
overall selectivity (but only marginally better than Rubb12),
while Rubb7-Cl showed the best selectivity towards the Gram-
negative E. coli.
The liver cell line HepG2 was chosen to determine the cyto-
toxicities of the ruthenium complexes in liver cells. The cyto-
toxicities of the ruthenium complexes against HepG2 cells
were determined after a 24-hour incubation, and the results
are summarised in Table 3. The HepG2 cells were more sus-
ceptible than the kidney cells to Rubb7-Cl and Rubb12-Cl, but
were more resistant to Rubb16-Cl. Interestingly, and unlike
what was observed with the BHK and HEK-293 cells, the cyto-
toxicities of the Rubbn-Cl complexes decreased with increasing
chain length in the bbn ligand. Surprisingly, Rubb7-Cl was the
most cytotoxic of all the ruthenium complexes assayed against
the HepG2 cells, with the 24 h-IC50 being 3.7 µM. The com-
parative selectivities between the two kidney cell lines and the
HepG2 cell line were calculated for each of the ruthenium
complexes and the results are summarised in Table 3. Rubb7-Cl
clearly exhibited significantly higher toxicity towards the
HepG2 cell line − compared to the two kidney cell lines − than
did the other ruthenium complexes. Although the relative
difference was much smaller, Rubb12-Cl was the only
other complex to show some preferential toxicity to the HepG2
cells.
Cellular localisation of rac-Rubbn-Cl complexes in HepG2 cells
Cellular localisation patterns are important in unravelling the
mechanism of cytotoxicity for any drug. Therefore, the intrin-
sic phosphorescence properties of the ruthenium complexes
were used to study their cellular localisation by laser-scanning
confocal microscopy. To achieve this, the ruthenium complex
phosphorescence patterns were overlaid with the fluorescence
patterns of DNA/RNA/mitochondria-specific stains in co-
labelling experiments.
As shown in Fig. 7, the rac-Rubbn-Cl complexes showed
similar nucleolus localisation to that previously reported for
the inert Rubbn complexes.
22 The nucleolus of HepG2 cells
were stained by Rubbn-Cl and SYTO 9. In addition to SYTO
9-stained rRNA, the most toxic complex Rubb7-Cl also showed
localisation with DAPI-stained DNA. By contrast, Rubb12-Cl
and Rubb16-Cl overlaid more with SYTO 9-stained rRNA in the
nucleolus, and less with DAPI-stained DNA. In particular,
Rubb12-Cl was exclusively localised in the nucleolus. These
results suggest that Rubb12-Cl and Rubb16-Cl have greater
selectivity for rRNA, compared to DNA, than does Rubb7-Cl.
BHK cells incubated with Rubb7-Cl at a concentration of
100 μM (approx. 50% of the IC50) for 20 hours are shown in
Fig. 8. The Rubb7-Cl phosphorescence is observed throughout
the cytoplasm and in the nucleus; however, within the nucleus
the phosphorescence was mainly in the nucleolus, with little
overlay with the DAPI-stained DNA. When BHK cells were incu-
bated with Rubb7-Cl at a concentration of 50 μM for 20 hours,
almost no phosphorescence was observed in the nucleus, with
only relatively weak accumulation of the ruthenium complex
in the cytoplasm (see Fig. 9).
Table 2 24 h-IC50 values (µM) of the ruthenium complexes against BHK and HEK-293 cells, and selectivity indices SI = 24 h-IC50/MIC, of the ruthe-
nium complexes between kidney cells (BHK and HEK-293) and two bacterial strains (S. aureus and E. coli)
Complexes
IC50 SI
BHK HEK-293 BHK vs. S. aureus BHK vs. E. coli HEK-293 vs. S. aureus HEK-293 vs. E. coli
Rac-Rubb7-Cl 238.1 ± 14.8 69.1 ± 5.6 42.5 340.1 12.3 98.7
Rac-Rubb12-Cl 47.4 ± 0.9 58.7 ± 2.1 67.7 67.7 83.9 83.9
Rac-Rubb16-Cl 22.6 ± 2.3 41.1 ± 1.9 32.3 8.4 58.7 15.2
ΔΔ-Rubb12 70.5 ± 26.4 50.9 ± 19.9 100.7 54.2 72.7 39.2
ΔΔ-Rubb16 29.8 ± 1.1 21.0 ± 10.8 49.7 24.8 35 17.5
Table 3 24 h-IC50 values (µM) of the ruthenium complexes against
HepG2 cells, and selectivity indices (SX) of the ruthenium complexes
compared to the kidney cell lines. SX is defined as the ratio of the IC50
against BHK or HEK-293 cells divided by the IC50 against the HepG2 cell
line
Complexes
IC50
SX
HepG2 BHK vs. HepG2 HEK-293 vs. HepG2
Rac-Rubb7-Cl 3.7 ± 0.7 64.4 18.7
Rac-Rubb12-Cl 24.3 ± 3.9 2.0 2.4
Rac-Rubb16-Cl 52.0 ± 2.9 0.4 0.8
ΔΔ-Rubb12 61.7 ± 5.5 1.1 0.8
ΔΔ-Rubb16 41.5 ± 2.9 0.7 0.5
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Discussion
We have previously demonstrated that the dinuclear ruthe-
nium complexes Rubbn and Cl-Rubbn-Cl have good antimicro-
bial activity.18,25 As would be expected, significant differences
in activity are observed upon changes to the total charge,
charge separation and lipophilicity of the ruthenium com-
plexes. To further investigate the interplay between these para-
meters, we have in this study synthesised and analysed the
antimicrobial activities of the Rubbn-Cl series of complexes.
The results demonstrate that the Rubbn-Cl complexes also
have good antimicrobial activity and are bactericidal, with the
most active complex against both Gram-positive and Gram-
negative strains being Rubb12-Cl. Similarly to what was
observed for the Rubbn complexes, the Rubbn-Cl complexes
were considerably more toxic to bacterial cells than towards
Fig. 7 Rac-Rubbn-Cl (red, a = Rubb7-Cl, b = Rubb12-Cl, c = Rubb16-Cl; 5 μM, 20 hour incubation) co-localisation in HepG2 cells with DAPI (blue)
and SYTO 9 (cyan), where the light colouration arises from co-localisation of SYTO 9 and Rubbn-Cl, and magenta colouration from co-localisation
of DAPI and ruthenium complexes. Scale bar = 10 μm.
Fig. 8 Rac-Rubb7-Cl (red; 100 µM; 20 hour incubation) co-localisation in BHK cells with DAPI (blue) and Mitotracker Green (green), where the light
colouration arises from co-localisation of Mitotracker Green and Rubb7-Cl, and magenta coloration from co-localisation of DAPI and Rubb7-Cl.
Scale bar = 10 μm.
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eukaryotic cells. With the exception of P. aeruginosa, Rubb12-Cl
was 35- to 84-times more toxic to the bacteria used in this
study than to BHK, HEK-293 or HepG2 cells. However, and
perhaps of greatest interest, was the observed toxicity profile of
Rubb7-Cl. Rubb7-Cl was eight- to sixteen-fold more active
against E. coli than the Gram-positive species, and even more
significantly, Rubb7-Cl was vastly less toxic towards BHK cells
but considerably more toxic towards HepG2 cells than Rubb12-Cl,
Rubb16-Cl, Rubb12 and Rubb16.
The preferential activity of Rubb7-Cl towards Gram-negative
E. coli over the Gram-positive species S. aureus and MRSA is
very unusual for a metal-based antimicrobial agent. A few
metal complexes have shown higher activity against Gram-
negative than Gram-positive bacteria. For example, two heli-
cate-like dinuclear iron complexes showed two-fold higher
activity against E. coli than S. aureus,35 and a [Ru2L3]
4+ triply-
stranded helicate complex also showed higher activity towards
E. coli than S. aureus, but the activities were modest.36
However, most metal complexes have shown greater antimicro-
bial activity against Gram-positive species than Gram-negative
species.9–11,18–25,37,38
The Rubbn-Cl complexes also showed a different pattern of
activities to the Rubbn and Cl-Rubbn-Cl complexes. Against the
Gram-positive bacteria, Rubb12-Cl and Rubb16-Cl were of equal
activity and considerably more active than Rubb7-Cl. However,
for the Gram-negative species, Rubb7-Cl and Rubb12-Cl were of
equal activity and were considerably more active than Rubb16-Cl.
For the Rubbn and Cl-Rubbn-Cl complexes, the same pattern
of activities was observed for all bacteria. For the Rubbn
complexes, the order of the activities across the four bacteria
was Rubb16 ≥ Rubb12 > Rubb7; while for the Cl-Rubbn-Cl
series, Cl-Rubb12-Cl > Cl-Rubb7-Cl ≥ Cl-Rubb16-Cl across the
bacteria. Although the differences are relatively small, Rubb12-Cl
showed the best activity profile against the four bacterial species
used in this study compared to any of the bbn-linked ruthenium
complexes that have been previously reported.18–25
Cytotoxicity assays against the kidney cell lines BHK and
HEK-293 and the liver cell line HepG2 were carried out to esti-
mate the toxicity of the Rubbn-Cl complexes towards mamma-
lian organ cells. In BHK and HEK-293 cells, the 24 h-IC50
values for the Rubbn-Cl series decreased with the increasing
number of methylene groups in the bbn ligand. A similar trend
was observed for the Rubbn complexes. These results suggest
that cellular uptake is the key parameter, at least to a first
approximation, with the uptake being correlated to the lipo-
philicity of the ruthenium complex. However, in HepG2 cells
the least lipophilic complex Rubb7-Cl exhibited the highest
cytotoxicity while the most lipophilic complex Rubb16-Cl was
the least toxic. Hence, it is probable that while lipophilicity is
important, at least in terms of cellular uptake, there are other
factors to be considered. Compared with healthy cells, the
cancer cell outer membrane leaflet contains three- to nine-
times more negatively-charged lipids and greater levels of
negatively-charged O-glycosylated mucins.39–41 In contrast, in
non-cancerous cells the membrane is largely occupied by
zwitterionic phospholipids, with negligible or weak negative
charge.42,43 In addition, the increased number of microvilli on
cancer cells, which lead to an increase in cell surface area, may
also enhance their susceptibility.44,45 Therefore, the cellular
uptake of the polycationic ruthenium complexes may be less
affected by lipophilicity in cancer cell lines compared with
healthy cells.
Intracellular localisation could also be an important aspect
of cytotoxicity. Confocal microscopy was used to determine the
cellular localisation of the Rubbn-Cl complexes in HepG2 cells.
The Rubbn-Cl complexes preferentially accumulated in the
nucleolus, while significant DNA binding was also observed at
higher concentrations. The preference for rRNA is consistent
with our previous studies on the localisation of Rubb12 in BHK
cells22 and Rubb16 in the ribosomes of E. coli.
21 However, the
Rubbn-Cl complexes showed differences in nuclear localisation
in HepG2 cells based upon the length of the alkyl chain in the
bbn linking ligand. The least lipophilic complex Rubb7-Cl
appeared to co-localise to a higher degree with DNA, while the
other two complexes, particularly Rubb12-Cl, showed greater
accumulation in the nucleolus. The effect of lipophilicity on
the cellular localisation of ruthenium complexes has been pre-
viously reported. Lincoln, Nordén and co-workers found the
length of an alkyl chain in a dppz-based complex (dppz =
dipyrido[3,2-a:2′,3′-c]phenazine) had a significant effect on the
Fig. 9 DAPI (blue) and rac-Rubb7-Cl (red; 50 µM; 20 hour incubation) localisation in BHK cells. Scale bar = 10 μm.
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localisation pattern – the least lipophilic complex was found to
stain nuclear DNA, the most lipophilic complex preferably
stained cellular membranes, whereas the derivative of inter-
mediate lipophilicity selectively stained the RNA-rich
nucleoli.46 Furthermore, Thomas and co-workers demon-
strated that the dinuclear complex [{Ru(phen)2}2{μ-tpphz}]4+
(where tpphz = tetrapyridophenazine) localised in the nucleus,
while the more lipophilic 4,7-diphenyl-1,10-phenanthroline
analogue [{Ru(DIP)2}2{μ-tpphz}]4+ localised in the endoplasmic
reticulum.47,48 While other factors are yet to be examined, the
greater level of DNA localisation in HepG2 by Rubb7-Cl, com-
pared to Rubb12-Cl and Rubb12, could be related to its higher
cytotoxicity against this cell line. Consistent with this proposal
was the observed low level of DNA binding, compared to that
in the nucleolus and cytoplasm, by Rubb7-Cl in BHK cells at
concentrations considerably higher than the 24 h-IC50 deter-
mined against HepG2 cells.
In conclusion, a new class of dinuclear ruthenium com-
plexes, Rubbn-Cl, has been synthesised and characterised.
These ruthenium complexes exhibited good antimicrobial
activities; and interestingly, showed relatively better activity
towards Gram-negative bacteria, (compared to Gram-positive
species) than previously reported ruthenium complexes linked
by the bbn ligand. In addition, the Rubbn-Cl complexes were
considerably less toxic to eukaryotic cells, compared to bac-
teria, with Rubb7-Cl showing striking differences in cytotoxicity
between the eukaryotic cell lines. It is possible that Rubb7-Cl
could become a new lead compound for metal-based anticancer
or antimicrobial agents.
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